Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole vs Swallowed Fluticasone for Eosinophilic Esophagitis
NCT00123656Phase 2Completed
- Sponsor
- University of Utah
- Start
- Aug 2004
- Primary completion
- Dec 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of fluticasone in eosinophilic esophagitis (EoE) (2 arms), sponsored by University of Utah. Primary endpoint: Change in eosinophil infiltration at 8 weeks. Started Aug 2004; status: completed.
02
Drugs
fluticasone
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT00123656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00123656.